# FDA recall D-1064-2016

> **Allergan Sales, LLC** · Class II · drug recall initiated 2016-05-10.

## Product

Tazorac (tazarotene) Gel 0.05%, Rx only, packaged in a) 30g (NDC 0023-8335-03) and b) 100g (NDC 0023-8335-10) tubes, Allergan Inc, Irvine, CA 92612

## Reason for recall

Failed Content Uniformity Specifications.

## Distribution

Nationwide and Puerto Rico

## Key facts

- **Recall number:** D-1064-2016
- **Recalling firm:** Allergan Sales, LLC
- **Classification:** Class II
- **Product type:** drug
- **Status:** Terminated
- **Initiation date:** 2016-05-10
- **Report date:** 2016-07-13
- **Termination date:** 2017-12-06

- **Voluntary/Mandated:** Voluntary: Firm initiated
- **Location:** Waco, TX, United States

## Primary source

FDA Enforcement Reports: https://www.accessdata.fda.gov/scripts/ires/index.cfm?Product=D-1064-2016

## Citation

> AI Analytics. FDA recall D-1064-2016. Retrieved 2026-06-01 from https://api.ai-analytics.org/recall/D-1064-2016. Source: US FDA. Licensed CC0.

---

*[Dataset catalog](/datasets/) · [FDA recalls dataset](/datasets/fda-recalls) · CC0 1.0*